2021 Announcements

CLINUVEL
Posted by CLINUVEL
August 26, 2021

Appendix 4E and Preliminary Financial Report

Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
August 26, 2021

CLINUVEL Delivers Record Revenues and Profit

Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
August 26, 2021

Dividend/Distribution - CUV

Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
August 10, 2021
CLINUVEL
Posted by CLINUVEL
August 10, 2021

Afamelanotide well tolerated by first stroke patients

CLINUVEL’s drug afamelanotide was well tolerated by the first three arterial ischaemic...

Read More
CLINUVEL
Posted by CLINUVEL
July 29, 2021

Appendix 4C & Activity Report

Melbourne, Australia, 29 July 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
July 14, 2021

Insider Insights III: Willem Blijdorp - Challenges & the Future

CLINUVEL today launches the third and final part of the Insider Insights...

Read More
CLINUVEL
Posted by CLINUVEL
July 7, 2021
CLINUVEL
Posted by CLINUVEL
July 5, 2021

Appendix 3Y Change of Director's Interest Notice

Information or documents not available now must be given to ASX as...

Read More
CLINUVEL
Posted by CLINUVEL
June 30, 2021

Insider Insights: Willem Blijdorp - Chair of The CLINUVEL Group

CLINUVEL today launched the Insider Insights series, featuring Chair Willem Blijdorp on...

Read More
CLINUVEL
Posted by CLINUVEL
June 29, 2021

Appendix 3Y Change of Director's Interest Notice

Information or documents not available now must be given to ASX as...

Read More
CLINUVEL
Posted by CLINUVEL
June 10, 2021

CLINUVEL Kommuniqué III

Sehr geehrte Aktionärinnen und Aktionäre, liebeFreunde, EINFÜHRUNG Während des Lockdown hatte unser...

Read More
CLINUVEL
Posted by CLINUVEL
June 7, 2021

Media Release - First stroke patient treated with afamelanotide

Melbourne, Australia, 07 June 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 7, 2021

First stroke patient treated with afamelanotide

Melbourne, Australia, 07 June 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 3, 2021

CLINUVEL Communiqué III

Dear shareholders, friends, INTRODUCTION During the lockdowns our team has had plenty...

Read More
We use cookies to give you the best experience.